Crystal Bio Solutions logo

Sep 16, 2025

An LC-MS/MS Method for Oligonucleotide PK Bioanalysis

Case study: a validated ion-pair LC-MS/MS method for oligonucleotide PK bioanalysis (2.00–2000 ng/mL, about 4.1 min per sample), applied in a Phase 1 clinical study.

An LC-MS/MS Method for Oligonucleotide PK Bioanalysis\

Summary: Crystal Bio Solutions developed and validated an ion-pair LC-MS/MS method for quantifying an oligonucleotide in plasma over 2.00–2000 ng/mL, with a run time of about 4.1 minutes per sample. The method was applied to PK samples from a Phase 1 clinical study.

Objective

Oligonucleotides are short nucleic acid molecules that are increasingly developed as therapeutics. Quantifying them in nonclinical and clinical samples is technically demanding. The goal of this study was to develop, validate and apply a fast, sensitive and reproducible LC-MS/MS method for oligonucleotide PK bioanalysis in an early-phase clinical study.

Challenges

  • The hydrophilic, negatively charged backbone gives poor retention on conventional reversed-phase columns.
  • Peak tailing and poor peak shape make carryover difficult to control.
  • MS response decreases as oligonucleotide molecular weight increases.
  • Matrix interference is strong and extraction recovery can be low.
  • The polyanionic structure causes sample loss through non-specific binding.

Approach

  • Ion-pair mobile phases based on HFIP/TEA (mobile phases A and B)
  • Oligonucleotide BEH C18 column (2.1 × 50 mm)
  • Optimized gradient elution
  • Simple sample preparation by protein precipitation (PPT)
  • Isotope-labeled oligonucleotide internal standard

Validation results

Validation result summary
ParameterResult
Calibration range2.00–2000 ng/mL (R² = 0.9939)
Internal standardIsotope-labeled oligonucleotide
Sample preparationProtein precipitation (PPT)
Accuracy%Bias −6.5% to 7.0%
Precision%CV < 8.8%
Selectivity100% of lots passed
Interference (analyte and IS)Passed
Dilution integrity (20×)%CV 1.3%; %Bias 0.3%
Matrix effectMatrix factor %CV 1.6%; 6/6 lots passed
Recovery76.3%
StabilityProcessed samples: 144.91 h at 4 °C, 6.13 h at room temperature; 5 freeze–thaw cycles; 19.73 h at 4 °C; 45 days at −80 °C
LC-MS/MS chromatograms of a double blank and an LLOQ sample, and the oligonucleotide standard curve
Figure 1. Representative chromatograms of a double blank and an LLOQ sample, and the standard curve (2.00–2000 ng/mL; R² = 0.9939).

Conclusions

  • The LC-MS/MS method was fully validated for sensitivity, accuracy, precision, selectivity, recovery and matrix effect.
  • With a run time of about 4.1 minutes per sample, the method was used to analyze PK samples from a Phase 1 clinical study.

Related services: PK assays for biologics and ADCs · Bioanalysis and biomarkers.

Download the case study

Fill in the short form below and we will email you the PDF (1 page, 580 KB).

To discuss a similar study, email cbs_bd@crystalpharmatech.com or call +1 925-558-5040.